Ryuichi Inoue
Overview
Explore the profile of Ryuichi Inoue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kakimoto H, Okurano M, Nagasato A, Kawata S, Mashima K, Sumi Y, et al.
Gan To Kagaku Ryoho
. 2024 Jul;
51(6):631-635.
PMID: 39009521
Hypersensitivity reactions are an adverse effect of anticancer drug therapy. Prophylactic administration of antiallergic drugs and steroids is recommended when administering drugs associated with a high hypersensitivity reaction incidence. First-generation...
2.
Uchiyama M, Miyazaki M, Hayashi T, Shimokawa M, Nakano T, Kakimoto H, et al.
J Geriatr Oncol
. 2024 Jun;
15(6):101814.
PMID: 38851083
Introduction: The Cancer and Aging Research Group (CARG) prediction tool was designed in the United States to predict grade ≥ 3 chemotherapy-related adverse events (CRAE) in older patients. However, its...
3.
Sakai T, Kondo M, Kawana Y, Inoue R
Rinsho Shinkeigaku
. 2022 Mar;
62(3):190-197.
PMID: 35228461
We report the case of a 51-year-old woman who developed neuromyelitis optica spectrum disorders (NMOSD) associated with primary biliary cholangitis (PBC). When she was 38 years old, she subacutely developed...
4.
Higashi D, Egawa Y, Hirano Y, Hirano K, Miyake T, Takahashi H, et al.
Anticancer Res
. 2014 Jul;
34(8):4595-9.
PMID: 25075105
Background: 5-Fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX) therapy and 5-FU, leucovorin, and irinotecan (FOLFIRI) therapy are standard chemotherapies to treat advanced/recurrent colorectal cancer. However, these chemotherapies require continuous infusion of...